Advertisement

ADVERTISEMENT

outcomes research

Research in Review
Aggressive Care Associated With Poorer Outcomes for Patients With NSCLC at End-of-Life
05/26/2017
JCP Editors
Aggressive care within the last month of life for patients with non-small cell lung cancer (NSCLC) is associated with lower family evaluations of end-of-life care, according to new research. ----- Related...
Aggressive care within the last month of life for patients with non-small cell lung cancer (NSCLC) is associated with lower family evaluations of end-of-life care, according to new research. ----- Related...
...
05/26/2017
Journal of Clinical Pathways
Research in Review
ASCT Deemed Safe and Effective for Older Patients With B-Cell Malignancies
05/25/2017
JCP Editors
Older patients with B-cell malignancies benefit from progression-free survival (PFS) and overall survival (OS) improvements after autologous stem cell transplantation (ASCT), according to research that will be...
Older patients with B-cell malignancies benefit from progression-free survival (PFS) and overall survival (OS) improvements after autologous stem cell transplantation (ASCT), according to research that will be...
Older...
05/25/2017
Journal of Clinical Pathways
Research in Review
Triple Combination Active in High-Risk B-Cell Malignancies
05/24/2017
JCP Editors
A combination of 3 pathway inhibitors is well tolerated with activity observed in heavily pre-treated and high-risk B-cell malignancies, according to research that will be presented at the ASCO Annual Meeting (June...
A combination of 3 pathway inhibitors is well tolerated with activity observed in heavily pre-treated and high-risk B-cell malignancies, according to research that will be presented at the ASCO Annual Meeting (June...
A...
05/24/2017
Journal of Clinical Pathways
Research in Review
Targeted Therapy May Improve Outcomes for Patients With Multiple Myeloma
05/22/2017
JCP Editors
Targeted therapy against a particular protein has the potential to improve outcomes and fracture-free survival for patients with multiple myeloma, according to research that will be presented at the 2017 ASCO...
Targeted therapy against a particular protein has the potential to improve outcomes and fracture-free survival for patients with multiple myeloma, according to research that will be presented at the 2017 ASCO...
...
05/22/2017
Journal of Clinical Pathways
Research in Review
Immune Checkpoint Inhibitors May Increase Response to CAR-T Therapy in ALL
05/19/2017
JCP Editors
Pembrolizumab improves response to chimeric antigen receptor (CAR) T-cell treatments in pediatric patients with B-cell relapsed acute lymphoblastic leukemia (ALL), according to research that will be presented at...
Pembrolizumab improves response to chimeric antigen receptor (CAR) T-cell treatments in pediatric patients with B-cell relapsed acute lymphoblastic leukemia (ALL), according to research that will be presented at...
...
05/19/2017
Journal of Clinical Pathways
Research in Review
Trastuzumab Emtansine Improves OS in Patients With HER2+ Breast Cancer
05/19/2017
JCP Editors
Patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer benefit from an estimated 7 additional months of survival if treated with trastuzumab emtansine rather than the physician’s choice...
Patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer benefit from an estimated 7 additional months of survival if treated with trastuzumab emtansine rather than the physician’s choice...
...
05/19/2017
Journal of Clinical Pathways
Research in Review
Targeted Therapy Improves Disease-Free Survival in Intermediate-Risk NSCLC
05/18/2017
JCP Editors
Adjuvant treatment with the targeted therapy gefitinib (Iressa, AstraZeneca) significantly improved disease-free survival (DFS) over standard of care after surgery for patients with non–small cell lung cancer...
Adjuvant treatment with the targeted therapy gefitinib (Iressa, AstraZeneca) significantly improved disease-free survival (DFS) over standard of care after surgery for patients with non–small cell lung cancer...
...
05/18/2017
Journal of Clinical Pathways
Research in Review
Prostate Cancer Subtypes Respond Differently to Androgen Deprivation Therapy
05/17/2017
JCP Editors
Luminal and basal subtyping of prostate cancer may provide a clinical tool for predicting which patients will benefit from androgen deprivation therapy (ADT) after prostatectomy, according to a report published in...
Luminal and basal subtyping of prostate cancer may provide a clinical tool for predicting which patients will benefit from androgen deprivation therapy (ADT) after prostatectomy, according to a report published in...
...
05/17/2017
Journal of Clinical Pathways
Research in Review
PD-L1 Expression Associated With Radiation Resistance in Head and Neck Cancer
05/16/2017
JCP Editors
PD-L1 expression may be a biomarker of local failure in human papillomavirus (HPV)-negative head and neck squamous cell carcinoma following radiotherapy, according to research published in Clinical Cancer Research...
PD-L1 expression may be a biomarker of local failure in human papillomavirus (HPV)-negative head and neck squamous cell carcinoma following radiotherapy, according to research published in Clinical Cancer Research...
PD-L1...
05/16/2017
Journal of Clinical Pathways
Guideline-Recommended Therapy Underused in Rare Form of Bladder Cancer
05/16/2017
JCP Editors
Recommended primary treatment for non-muscle invasive micropapillary urothelial carcinoma (MPBC) is often foregone in community cancer centers and academic centers, according to a study presented at the American...
Recommended primary treatment for non-muscle invasive micropapillary urothelial carcinoma (MPBC) is often foregone in community cancer centers and academic centers, according to a study presented at the American...
...
05/16/2017
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

December 4 ⁠–⁠ December 5
Great Debates & Updates in Diabetic Foot
December 6 ⁠–⁠ December 7
AIBD logo
December 9 ⁠–⁠ December 11
December 9 ⁠–⁠ December 11
Psych Congress Primary Care Online Series
December 12 ⁠–⁠ December 13
December 14 ⁠–⁠ December 15
February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use